NEW METHOD OF EVALUATING MUSCLE FUNCTION WITH MAGNETIC RESONANCE IMAGER

使用磁共振成像仪评估肌肉功能的新方法

基本信息

  • 批准号:
    15500365
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2005
  • 项目状态:
    已结题

项目摘要

Purpose :To determine whether muscle fiber atrophy associated with steroid myopathy can be detected with T2 relaxation time.Materials and Methods:Animal and human studies were approved by the ethics committee. Informed consent was obtained. Twelve rabbits were divided into a group that received 3 mg/kg of triamcinolone subcutaneously each day for 10 consecutive days (n_6) and a control group that received saline (n_6). Magnetic resonance (MR) imaging was performed before and after treatment. T2 and fat deposition ratio (FDR) of soleus and gastrocnemius muscles before and after treatment and between control rabbits and rabbits treated with steroids were compared by using two-way repeated analysis of variance and Bonferroni post hoc test to evaluate effects of steroid treatment. After imaging, rabbits were sacrificed. Extracellular space ratio (ECSR) and fiber diameter were examined. Correlation among T2, ECSR, and diameter of type 2 muscle fibers was analyzed with a Pearson correlation … More test with Bonferroni correction in gastrocnemius to determine factors affecting T2. In humans, T2 relaxation time and FDR of both muscles were compared between volunteers not treated with steroids and patients treated with steroids by using an unpaired t test to evaluate the effects of steroids.Results :In rabbits, T2 of gastrocnemius muscle was significantly (P_.01) longer after steroid treatment than before steroid treatment and was also significantly (P_.01) longer than after saline administration. T2 of the gastrocnemius showed no significant difference in control rabbits before or after saline administration or in control rabbits and rabbits before steroid administration. T2 of the soleus muscle or FDR of either muscle showed no significant difference. There was a significant correlation (P_.01) among T2, ECSR, and diameter of type 2 muscle fibers in the gastrocnemius. In humans, T2 of the gastrocnemius was significantly (P_.01) longer in patients than in volunteers. T2 of the soleus or FDR of eithermuscle showed no significant difference.Conclusion :Muscle fiber atrophy associated with steroid myopathy is detectable as prolongation of T2 relaxation time in the gastrocnemius muscle ; the authors believe prolongation of T2 relaxation time is mainly due to increased ECSR reflecting type 2 muscle fiber atrophy. Less
目的:以确定是否与类固醇肌病相关的肌纤维萎缩可以检测T2弛豫time.Materials和方法:动物和人体研究的伦理委员会批准。获得知情同意。12只家兔随机分为两组,一组给予曲安奈德3 mg/kg皮下注射,每日1次,连续10天(n_6),另一组给予生理盐水。治疗前后均行磁共振(MR)检查。采用双向重复方差分析和Bonferroni事后检验比较激素治疗前后及对照组和激素治疗组家兔比目鱼肌和腓肠肌的T2和脂肪沉积率(FDR),以评价激素治疗的效果。成像后,处死家兔。测定细胞外间隙比(ECSR)和纤维直径。T2、ECSR和2型肌纤维直径之间的相关性用Pearson相关分析 ...更多信息 测试腓肠肌Bonferroni校正,以确定影响T2的因素。在人类中,T2松弛时间和FDR的两块肌肉进行了比较志愿者之间没有用类固醇和类固醇治疗的患者通过使用非配对t检验,以评估类固醇的效果。结果:在兔子,腓肠肌T2类固醇治疗后显着(P_0.01)比类固醇治疗前,也显着(P_0.01)比生理盐水给药后更长。对照组家兔在生理盐水给药前后或激素给药前与对照组家兔腓肠肌T2均无显著性差异。比目鱼肌的T2或任一肌肉的FDR没有显示显著差异。T2、ECSR和腓肠肌2型肌纤维直径之间存在显著相关性(P_0.01)。在人体中,患者腓肠肌的T2显著(P_0.01)长于志愿者。结论:类固醇肌病伴肌纤维萎缩表现为腓肠肌T2弛豫时间延长,作者认为T2弛豫时间延长主要是由于反映2型肌纤维萎缩的ECSR增加所致。少

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Steroid Myopathy : Evaluation of Fiber Atrophy with T2 Relaxation Time-Rabbit and Human Study
类固醇肌病:用 T2 弛豫时间评估纤维萎缩-兔和人体研究
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hatakenaka M et al.
  • 通讯作者:
    Hatakenaka M et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HATAKENAKA Masamitsu其他文献

HATAKENAKA Masamitsu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HATAKENAKA Masamitsu', 18)}}的其他基金

Evaluation of neuromuscular disease activity by diffusion tensor imaging
通过扩散张量成像评估神经肌肉疾病活动性
  • 批准号:
    22591341
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel MR parameters associated with left ventricular contraction
开发与左心室收缩相关的新 MR 参数
  • 批准号:
    18591353
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New approach for evaluating muscle function by using MR imaging
使用 MR 成像评估肌肉功能的新方法
  • 批准号:
    12832035
  • 财政年份:
    2000
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
Approaches to elucidate the molecular pathogenesis of oculopharyngodistal myopathy using single cell RNA sequencing
利用单细胞 RNA 测序阐明眼咽远端肌病分子发病机制的方法
  • 批准号:
    23K14782
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Resistance exercise to mitigate glucocorticoid myopathy during Alzheimer’s
抗阻运动可减轻阿尔茨海默病期间的糖皮质激素肌病
  • 批准号:
    10667849
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Enhance myogenic transdifferentiation efficiency using engineering approaches
利用工程方法提高生肌转分化效率
  • 批准号:
    10647491
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
A bioluminescent-based imaging probe for noninvasive longitudinal monitoring of CoQ10 uptake in vivo
基于生物发光的成像探针,用于体内 CoQ10 摄取的无创纵向监测
  • 批准号:
    10829717
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
A novel framework for nanomedicine development
纳米医学开发的新框架
  • 批准号:
    10715013
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Massively-parallel functional interrogation of genetic variation in CMD-associated alpha-dystroglycan glycosylating enzymes
CMD 相关 α-肌营养不良聚糖糖基化酶遗传变异的大规模并行功能询问
  • 批准号:
    10802855
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Gut stress-induced intercellular signaling networks promoting longevity and proteostasis
肠道应激诱导的细胞间信号网络促进长寿和蛋白质稳态
  • 批准号:
    10717808
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Small molecule therapeutics for myotonic dystrophy type 1
1 型强直性肌营养不良的小分子疗法
  • 批准号:
    10583984
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Evaluation of adeno-associated viral (AAV) mediated gene replacement therapy as a therapeutic option for SLC25A4 deficiency
评估腺相关病毒 (AAV) 介导的基因替代疗法作为 SLC25A4 缺陷的治疗选择
  • 批准号:
    10606065
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了